- Home
- PRQR vs JRS Comparison
PRQR vs JRS Comparison
Compare PRQR & JRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRQR
- JRS
- Stock Information
- Founded
- PRQR 2012
- JRS 2001
- Country
- PRQR Netherlands
- JRS United States
- Employees
- PRQR N/A
- JRS N/A
- Industry
- PRQR Biotechnology: Pharmaceutical Preparations
- JRS Finance/Investors Services
- Sector
- PRQR Health Care
- JRS Finance
- Exchange
- PRQR Nasdaq
- JRS Nasdaq
- Market Cap
- PRQR 309.5M
- JRS 267.5M
- IPO Year
- PRQR 2014
- JRS N/A
- Fundamental
- Price
- PRQR $2.67
- JRS $8.51
- Analyst Decision
- PRQR Strong Buy
- JRS
- Analyst Count
- PRQR 5
- JRS 0
- Target Price
- PRQR $7.60
- JRS N/A
- AVG Volume (30 Days)
- PRQR 603.0K
- JRS 86.6K
- Earning Date
- PRQR 11-07-2024
- JRS 01-01-0001
- Dividend Yield
- PRQR N/A
- JRS 8.87%
- EPS Growth
- PRQR N/A
- JRS N/A
- EPS
- PRQR N/A
- JRS N/A
- Revenue
- PRQR $20,506,357.00
- JRS N/A
- Revenue This Year
- PRQR $235.11
- JRS N/A
- Revenue Next Year
- PRQR N/A
- JRS N/A
- P/E Ratio
- PRQR N/A
- JRS N/A
- Revenue Growth
- PRQR 306.68
- JRS N/A
- 52 Week Low
- PRQR $1.61
- JRS $5.95
- 52 Week High
- PRQR $4.62
- JRS $8.00
- Technical
- Relative Strength Index (RSI)
- PRQR 38.02
- JRS 36.25
- Support Level
- PRQR $2.48
- JRS $8.05
- Resistance Level
- PRQR $2.71
- JRS $9.48
- Average True Range (ATR)
- PRQR 0.29
- JRS 0.20
- MACD
- PRQR -0.08
- JRS -0.10
- Stochastic Oscillator
- PRQR 28.09
- JRS 32.17
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.
About JRS Nuveen Real Estate Income Fund of Beneficial Interest
Nuveen Real Estate Income Fund is a diversified closed-end investment company. The Fund invests primarily in income-producing common stocks, preferred stocks, convertible preferred stocks, and debt securities issued by real estate companies. At least 75% of the Fund's managed assets will be in securities rated investment grade.